Compartilhar
Informação da revista
Conteúdo especial sobre o coronavírus SARS-CoV-2 (COVID-19) em Hematology, Transfusion and Cell Therapy
QUALITY OF LIFE IN HEMATOLOGICAL PATIENTS IN THE POST-COVID ERA
Weronika Lebowa, Karol Miklusiak, Ositadima Chukwu, Agnieszka Giza, Tomasz Sacha
10.1016/j.htct.2022.09.1257
Hematol Transfus Cell Ther. 2022;44 Supl 1:S36-7
Open access
GRISCELLI SYNDROME TYPE 2 –CLINICAL APPROACH AND CASE REPORT
Konul Baghirova, Gular Mammadova, Avesta Allahverdiyeva, Narmin Eyvazova, Narmin Verdiyeva, Agarza Agayev, Samira Hasanova, Valeh Huseynov
10.1016/j.htct.2022.09.1263
Hematol Transfus Cell Ther. 2022;44 Supl 1:S39
Open access
Vaccination Against SARS-CoV-2 for Myeloma Patients: Do We Need a Booster Dose and How Frequent?
Evangelos Terpos
10.1016/j.htct.2022.09.1191
Hematol Transfus Cell Ther. 2022;44 Supl 1:S4-5
Open access
THE EFFECT OF THE COVID-19 PANDEMIC PROCESS ON TREATMENT COMPLIANCE IN HEMOPHILIA PATIENTS
Şifa Şahin, Serap Karaman, Yasin Yılmaz, Mustafa Bilici, Saadet Aslan, Hikmet Gülşah Tanyıldız, Deniz Tuğcu, Zeynep Karakaş, Ayşegül Ünüvar
10.1016/j.htct.2022.09.1224
Hematol Transfus Cell Ther. 2022;44 Supl 1:S21-2
Open access
IMPACT OF COVID-19 PANDEMIC ON DELAY OF CHILDHOOD CANCER DIAGNOSIS AND THE OUTCOMES IN A PEDIATRIC HEMATOLOGY/ONCOLOGY DEPARTMENT
Selma CAKMAKCI, Neriman SARI, Arzu YAZAL ERDEM, Sonay INCESOY OZDEMIR, Derya OZYORUK, Aslınur OZKAYA PARLAKAY, İnci ERGURHAN ILHAN
10.1016/j.htct.2022.09.1229
Hematol Transfus Cell Ther. 2022;44 Supl 1:S24
Open access
Severe Relapsed Autoimmune Hemolytic Anemia after Booster with mRNA-1273 COVID-19 vaccine
Flordeluna Z. Mesina
10.1016/j.htct.2022.05.001
Open access
Disponível online em 6 de Junho de 2022
Immune thrombocytopenia in a patient with essential thrombocythemia after SARS-CoV-2 infection: A case report
Barbora Bacova, Maria Maco, Lucie Geislerova, Ivana Zubata, Tomas Kozak, Jan Novak
10.1016/j.htct.2022.03.001
Open access
Disponível online em 10 de Maio de 2022
Development and implementation of a COVID-19 convalescent plasma program in a middle-income economy
Gustavo de Carvalho Duarte, Vivian Simoni, Glaciano Nogueira Ribeiro, Ricardo Haddad, Mariangela Moschen, Rodrigo Spessotto Morais Toledo, Maria Angela Pignata Ottoboni, Alfredo Mendrone-Junior, Dante Mario Langhi
10.1016/j.htct.2022.01.001
Hematol Transfus Cell Ther. 2022;44:206-12
Open access
Association between FY*02N.01 and the severity of COVID-19: initial observations
Marina C.A.V. Conrado, Marcia R. Dezan, Valéria Brito Oliveira, Karen Chinoca Ziza, Tila Fanciscani, Vanderson Rocha, Alfredo Mendrone-Júnior, Carla Luana Dinardo
10.1016/j.htct.2022.01.002
Hematol Transfus Cell Ther. 2022;44:213-7
Open access
Hematological changes in SARS-COV-2 positive patients
Mafalda Urbano, Elísio Costa, Catarina Geraldes
10.1016/j.htct.2021.12.001
Hematol Transfus Cell Ther. 2022;44:218-24
Open access
Conteúdo especial sobre COVID-19
Publicar em
Hematology, Transfusion and Cell Therapy
A revista pertence ao Committee on Publication Ethics (COPE) www.publicationethics.org e adere aos seus princípios e procedimentos.